These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17523419)

  • 21. [The analysis of adequacy of the treatment for acute otitis media and bacterial sinusitis in outpatient setting].
    Kriukov AI; Turovskiĭ AB; Balandin AV; Khamzalieva RB; Subbota DV
    Vestn Otorinolaringol; 2006; (1):61-4. PubMed ID: 16482017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Office treatment of infection. 1. Respiratory infections.
    Fekety R
    Postgrad Med; 1980 Feb; 67(2):74-83. PubMed ID: 6766213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An approach to pediatric upper respiratory infections.
    Middleton DB
    Am Fam Physician; 1991 Nov; 44(5 Suppl):33S-40S, 46S-47S. PubMed ID: 1950981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary: antibiotic recommendations for acute otitis media and acute bacterial sinusitis in 2013--the conundrum.
    Wald ER; DeMuri GP
    Pediatr Infect Dis J; 2013 Jun; 32(6):641-3. PubMed ID: 23340557
    [No Abstract]   [Full Text] [Related]  

  • 25. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 26. [Present positioning of levofloxacin in chemotherapy of bacterial infections].
    Iakovlev VP
    Antibiot Khimioter; 2008; 53(9-10):3-5. PubMed ID: 19441643
    [No Abstract]   [Full Text] [Related]  

  • 27. Infectious disease management with oral antibiotics.
    Meyers BR
    Infection; 1979; 7 Suppl 6():597-9. PubMed ID: 317813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial].
    Cooperation Group for Phase IV Clinical Study of Levofloxacin
    Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):492-6. PubMed ID: 19954047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From cystitis to bacterial prostatitis: experience with levofloxacin].
    Mirone V
    Infez Med; 2009 Dec; 17 Suppl 5():29-35. PubMed ID: 20424534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriological and clinical experiences with ofloxacin in urinary tract infections.
    Fröhlich G; Stratmeyer R
    Chemioterapia; 1987 Jun; 6(2 Suppl):525-6. PubMed ID: 3509489
    [No Abstract]   [Full Text] [Related]  

  • 31. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Sollet JP
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S113-4. PubMed ID: 16904296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of ofloxacin (Tarivid) therapy in respiratory and urinary tract infections].
    Hasçelik G
    Mikrobiyol Bul; 1987 Jul; 21(3):165-71. PubMed ID: 3332699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al.
    Gwaltney JM
    Diagn Microbiol Infect Dis; 2008 May; 61(1):21-2. PubMed ID: 18375085
    [No Abstract]   [Full Text] [Related]  

  • 34. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO
    Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Of bugs and drugs. A guide through the labyrinth of antimicrobial therapy for respiratory tract infections.
    Singh J; Arrieta AC
    Postgrad Med; 1999 Nov; 106(6):47-54; quiz 252. PubMed ID: 10576002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levofloxacin in patients with severe respiratory tract infection.
    Odagiri S
    Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I].
    Sidorenko SV; Ivanov DV
    Antibiot Khimioter; 2005; 50(1):3-10. PubMed ID: 16302640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy of infectious diseases. Chairman's summing-up and conclusions.
    Pechere JC
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):99-100. PubMed ID: 805652
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotic resistance and the need for the rational use of antibiotics.
    Hueston WJ; Dickerson L
    J Med Liban; 2001; 49(5):246-56. PubMed ID: 12243418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaerobic bacteria in upper respiratory tract and head and neck infections: microbiology and treatment.
    Brook I
    Anaerobe; 2012 Apr; 18(2):214-20. PubMed ID: 22197951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.